AKT1 and neoplasm: Similar studies have reported that 63% of the cases had at least one somatic mutation or copy number variation involving the PI3K-Akt signaling pathway in tumor samples, and biomolecular mutation or copy number variation in this pathway may be associated with increased PI3K-Akt signaling 85.